Evidence map›Paper›PMID 26355561›Full record

ArticleChemical research in toxicology2015

Scavenging 4-Oxo-2-nonenal.

Venkataraman Amarnath, Kalyani Amarnath

Open access · greenAbstract read
In one paragraph

Article in Chemical research in toxicology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. 2-Alkyl Furans Undergo Radiolytic Oxidative Protein Cross-Linking.Journal of the American Chemical Society · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Oxidative modification of HDL by lipid aldehydes impacts HDL function.Archives of biochemistry and biophysics · 2022
    Review
  6. Emerging Anti-Atherosclerotic Therapies.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Venkataraman AmarnathDepartment of Pathology, Microbiology and Immunology, and ‡Division of Clinical Pharmacology Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.
Kalyani AmarnathDepartment of Pathology, Microbiology and Immunology, and ‡Division of Clinical Pharmacology Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.
Vanderbilt University Medical Center · US

Funding

Prevention of COX-2 Derived DNA and Histone Modifications in CancerR21CA187495 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OATES, JOHN ALEXANDER · 2015 to 2016
$394k
NCI NIH HHS CA187495NCI NIH HHS R21 CA187495
6 · The paper itself

Abstract

4-Oxo-2-nonenal (ONE), a product of cellular lipid oxidation, reacts nonspecifically with the lysine residues of proteins and is generated in increased amounts during degenerative diseases and cancer. We show that pyridoxamine, salicylamine, and related 2-aminomethylphenols react with ONE, to form pyrrolo[2,1-b][1,3]oxazines with the participation of both the amino and the phenolic groups. 2-Aminomethylphenols react with ONE as well as with the Michael adducts of ONE much more rapidly than lysine, suggesting their use for therapeutically scavenging ONE.

Indexed as

AldehydesFree Radical ScavengersLipid PeroxidationLysineProteinsPyridoxaminePyrroles4-oxo-2-nonenalAldehydesFree Radical ScavengersLysineProteinsPyridoxaminePyrroles

Identifiers

PMID26355561
PMCPMC6579115
OpenAlexW2335945113

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.